REVIVA PHARMACEUTICALS HOLDINGS, INC.
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH): 2 pipeline candidates · ~18 mo cash runway · 1 clinical trial. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
17.8 months
D/E 0.35 · 0% dilution
Lead: Phase 2
2 candidates
N/A
N/A
A transparent, data-derived signal for REVIVA PHARMACEUTICALS HOLDINGS, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$9.1M
Cash
$22.2M
Quarterly Burn
$3.8M
Runway
17.8 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (2 candidates)
| Drug | Phase |
|---|---|
| brilaroxazine | — |
| rp5063 | Phase 2 |
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
35
Total value held
$2.9M
| Holder | Shares | Value |
|---|---|---|
| millennium management llc | 793,948 | $579K |
| highbridge capital management llc | 762,236 | $556K |
| jpmorgan chase & co | 762,236 | $556K |
| armistice capital, llc | 592,079 | $432K |
| susquehanna international group, llp | 527,800 | $385K |
| vanguard capital management llc | 235,136 | $172K |
| geode capital management, llc | 72,992 | $53K |
| renaissance technologies llc | 43,002 | $31K |
| vanguard fiduciary trust co | 31,598 | $23K |
| state street corp | 19,160 | $14K |
Showing top 10 of 35 institutional holders of REVIVA PHARMACEUTICALS HOLDINGS, INC.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in REVIVA PHARMACEUTICALS HOLDINGS, INC.'s pipeline?
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) has 2 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is REVIVA PHARMACEUTICALS HOLDINGS, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, REVIVA PHARMACEUTICALS HOLDINGS, INC. has approximately 17.8 months of cash runway.
What is REVIVA PHARMACEUTICALS HOLDINGS, INC.'s market capitalization?
REVIVA PHARMACEUTICALS HOLDINGS, INC.'s market capitalization is approximately $9.1M.
Who is the CEO of REVIVA PHARMACEUTICALS HOLDINGS, INC.?
Dr. Laxminarayan Bhat Ph.D. is the chief executive officer of REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH).
Get the full picture on REVIVA PHARMACEUTICALS HOLDINGS, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.